Skip to main content

Find Clinical Trials

Home
Conditions
Purpura

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

378 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Purpura trial results

Not Yet Recruiting

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

NCT07455006

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization

NCT07426107

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Autoimmune Diseases, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

NCT07416032

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

NCT07400250

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

NCT07354503

Conditions: Blood Coagulation Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

NCT07315373

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura

NCT07310342

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Armand de Villeneuve Hospital - Montpellier University Hospital Montpellier, France

Institut Saint-Pierre Palavas-les-Flots, France

Armand Trousseau Hospital - AP-HP Paris, France

Robert Debré Hospital - APHP Paris, France

View Trial Details

Not Yet Recruiting

The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia

NCT07298733

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

NCT07212322

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +46 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

NCT07278908

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details